Operating Expenses Summary of Acrux Limited

Acrux Limited's latest annual operating expenses in 2024 was 8.55 Million AUD , up 60.23% from previous year.
Acrux Limited's latest quarterly operating expenses in 2024 FY was 3.9 Million AUD , down -26.86% from previous quarter.
Acrux Limited reported a annual operating expenses of 5.33 Million AUD in annual operating expenses 2023, down -61.95% from previous year.
Acrux Limited reported a annual operating expenses of 14.02 Million AUD in annual operating expenses 2022, down -17.12% from previous year.
Acrux Limited reported a quarterly operating expenses of 3.9 Million AUD for 2024 FY, down -26.86% from previous quarter.
Acrux Limited reported a quarterly operating expenses of 4.43 Million AUD for 2024 Q4, down 0.0% from previous quarter.

Annual Operating Expenses Chart of Acrux Limited (2024 - 2002)

Historical Annual Operating Expenses of Acrux Limited (2024 - 2002)

Year	Operating Expenses	Operating Expenses Growth
2024	8.55 Million AUD	60.23%
2023	5.33 Million AUD	-61.95%
2022	14.02 Million AUD	-17.12%
2021	16.92 Million AUD	34.08%
2020	12.62 Million AUD	185.44%
2019	4.42 Million AUD	-72.72%
2018	16.2 Million AUD	-21.52%
2017	20.65 Million AUD	156.65%
2016	8.04 Million AUD	14.99%
2015	6.99 Million AUD	-5.67%
2014	7.41 Million AUD	21.9%
2013	6.08 Million AUD	10.09%
2012	5.52 Million AUD	-12.13%
2011	6.29 Million AUD	14.55%
2010	5.49 Million AUD	-51.07%
2009	11.22 Million AUD	-1.52%
2008	11.39 Million AUD	-10.56%
2007	12.74 Million AUD	-0.53%
2006	12.81 Million AUD	18.49%
2005	10.81 Million AUD	36.09%
2004	7.94 Million AUD	18.28%
2003	6.71 Million AUD	53.19%
2002	4.38 Million AUD	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q2	1.95 Million AUD	0.0%
2024 FY	3.9 Million AUD	-26.86%
2024 Q4	4.43 Million AUD	0.0%
2023 FY	5.33 Million AUD	-61.95%
2023 Q2	2.88 Million AUD	0.0%
2023 Q4	2.63 Million AUD	0.0%
2022 Q4	6.95 Million AUD	0.0%
2022 Q2	7.07 Million AUD	0.0%
2022 FY	14.02 Million AUD	-17.12%
2021 Q2	8.39 Million AUD	0.0%
2021 Q4	8.52 Million AUD	0.0%
2021 FY	16.92 Million AUD	34.08%
2020 FY	12.62 Million AUD	185.44%
2020 Q4	6.5 Million AUD	0.0%
2020 Q2	6.12 Million AUD	0.0%
2019 Q2	4.24 Million AUD	0.0%
2019 Q4	7.23 Million AUD	0.0%
2019 FY	4.42 Million AUD	-72.72%
2018 Q2	11.11 Million AUD	0.0%
2018 FY	16.2 Million AUD	-21.52%
2018 Q4	5.09 Million AUD	0.0%
2017 Q2	4.45 Million AUD	0.0%
2017 FY	20.65 Million AUD	156.65%
2017 Q4	16.19 Million AUD	0.0%
2016 FY	8.04 Million AUD	14.99%
2016 Q2	3.67 Million AUD	0.0%
2016 Q4	4.37 Million AUD	0.0%
2015 Q2	3.05 Million AUD	0.0%
2015 Q4	3.94 Million AUD	0.0%
2015 FY	6.99 Million AUD	-5.67%
2014 FY	7.41 Million AUD	21.9%
2014 Q4	3.92 Million AUD	0.0%
2014 Q2	3.49 Million AUD	0.0%
2013 FY	6.08 Million AUD	10.09%
2013 Q4	2.57 Million AUD	0.0%
2013 Q2	2.62 Million AUD	0.0%
2012 Q3	237.5 Thousand AUD	0.0%
2012 FY	5.52 Million AUD	-12.13%
2012 Q2	237.5 Thousand AUD	-46.45%
2012 Q1	443.5 Thousand AUD	0.0%
2012 Q4	- AUD	-100.0%
2011 Q4	- AUD	-100.0%
2011 FY	6.29 Million AUD	14.55%
2011 Q1	277.25 Thousand AUD	0.0%
2011 Q2	443.5 Thousand AUD	59.96%
2011 Q3	443.5 Thousand AUD	0.0%
2010 Q4	- AUD	-100.0%
2010 Q1	1.09 Million AUD	0.0%
2010 Q2	277.25 Thousand AUD	-74.65%
2010 Q3	277.25 Thousand AUD	0.0%
2010 FY	5.49 Million AUD	-51.07%
2009 Q1	503.5 Thousand AUD	0.0%
2009 FY	11.22 Million AUD	-1.52%
2009 Q2	1.09 Million AUD	117.18%
2009 Q4	- AUD	-100.0%
2009 Q3	1.09 Million AUD	0.0%
2008 Q4	- AUD	-100.0%
2008 Q2	503.5 Thousand AUD	38.32%
2008 Q1	364 Thousand AUD	0.0%
2008 FY	11.39 Million AUD	-10.56%
2008 Q3	503.5 Thousand AUD	0.0%
2007 Q4	- AUD	-100.0%
2007 Q2	364 Thousand AUD	-30.33%
2007 Q1	522.5 Thousand AUD	0.0%
2007 Q3	364 Thousand AUD	0.0%
2007 FY	12.74 Million AUD	-0.53%
2006 Q1	470.91 Thousand AUD	0.0%
2006 Q4	- AUD	-100.0%
2006 Q3	522.5 Thousand AUD	0.0%
2006 FY	12.81 Million AUD	18.49%
2006 Q2	522.5 Thousand AUD	10.95%
2005 Q3	470.91 Thousand AUD	0.0%
2005 Q4	- AUD	-100.0%
2005 FY	10.81 Million AUD	36.09%
2005 Q1	368.25 Thousand AUD	0.0%
2005 Q2	470.91 Thousand AUD	27.88%
2004 Q2	368.25 Thousand AUD	-78.07%
2004 Q3	368.25 Thousand AUD	0.0%
2004 Q4	- AUD	-100.0%
2004 FY	7.94 Million AUD	18.28%
2004 Q1	1.67 Million AUD	0.0%
2003 Q4	1.67 Million AUD	0.0%
2003 FY	6.71 Million AUD	53.19%
2003 Q2	1.67 Million AUD	53.19%
2003 Q3	1.67 Million AUD	0.0%
2003 Q1	1.09 Million AUD	0.0%
2002 Q3	1.09 Million AUD	0.0%
2002 Q2	1.09 Million AUD	0.0%
2002 Q4	1.09 Million AUD	0.0%
2002 FY	4.38 Million AUD	0.0%

Peer Operating Expenses Comparison of Acrux Limited

Name	Operating Expenses	Operating Expenses Difference
AdAlta Limited	6.76 Million AUD	-26.302%
Actinogen Medical Limited	22.77 Million AUD	62.451%
AnteoTech Limited	12.18 Million AUD	29.843%
Argenica Therapeutics Limited	8.26 Million AUD	-3.396%
Arovella Therapeutics Limited	10.78 Million AUD	20.725%
Anatara Lifesciences Ltd	710.21 Thousand AUD	-1103.857%
Alterity Therapeutics Limited	23.4 Million AUD	63.472%
Amplia Therapeutics Limited	8.43 Million AUD	-1.355%
Avecho Biotechnology Limited	4.54 Million AUD	-88.103%
Bio-Gene Technology Limited	2.76 Million AUD	-209.669%
Biome Australia Limited	7.91 Million AUD	-8.074%
Biotron Limited	5.11 Million AUD	-67.297%
Botanix Pharmaceuticals Limited	601.82 Thousand AUD	-1320.691%
BTC Health Limited	-1.03 Million AUD	922.964%
Chimeric Therapeutics Limited	19.76 Million AUD	56.747%
CSL Limited	7.56 Billion AUD	99.887%
Clarity Pharmaceuticals Ltd	56.3 Million AUD	84.815%
Clinuvel Pharmaceuticals Limited	31.29 Million AUD	72.681%
Cynata Therapeutics Limited	11.12 Million AUD	23.136%
Dimerix Limited	25.64 Million AUD	66.658%
EZZ Life Science Holdings Limited	39.57 Million AUD	78.395%
Hexima Limited	1 Million AUD	-747.584%
Island Pharmaceuticals Limited	4.12 Million AUD	-107.255%
Immuron Limited	9.13 Million AUD	6.434%
Immutep Limited	42.87 Million AUD	80.058%
Imugene Limited	135.09 Million AUD	93.671%
Invex Therapeutics Ltd	3.34 Million AUD	-155.538%
Memphasys Limited	3.67 Million AUD	-132.439%
Nanollose Limited	12.5 Thousand AUD	-68294.528%
Neuren Pharmaceuticals Limited	32.69 Million AUD	73.851%
Noxopharm Limited	7 Million AUD	-22.14%
NeuroScientific Biopharmaceuticals Limited	1.96 Million AUD	-335.066%
Nyrada Inc.	4.55 Million AUD	-87.699%
Orthocell Limited	15.36 Million AUD	44.37%
PharmAust Limited	6.65 Million AUD	-28.436%
Patrys Limited	4.93 Million AUD	-73.312%
Paradigm Biopharmaceuticals Limited	65.1 Million AUD	86.867%
Proteomics International Laboratories Limited	892.14 Thousand AUD	-858.367%
Prescient Therapeutics Limited	10.89 Million AUD	21.551%
PYC Therapeutics Limited	60.91 Million AUD	85.964%
Race Oncology Limited	14.77 Million AUD	42.114%
Radiopharm Theranostics Limited	299.22 Thousand AUD	-2757.353%
Recce Pharmaceuticals Ltd	21.68 Million AUD	60.571%
Starpharma Holdings Limited	22.81 Million AUD	62.526%
Telix Pharmaceuticals Limited	269.26 Million AUD	96.825%
Tissue Repair Ltd	6.66 Million AUD	-28.247%
Zelira Therapeutics Limited	5.94 Million AUD	-43.733%

Global Stocks Search

Acrux Limited (ACR.AX)

Operating Expenses Summary of Acrux Limited

Annual Operating Expenses Chart of Acrux Limited (2024 - 2002)

Historical Annual Operating Expenses of Acrux Limited (2024 - 2002)

Peer Operating Expenses Comparison of Acrux Limited